SERB Pharmaceuticals is a pharmaceutical company specialized in emergency care, critical care, and rare diseases, and a key player in the research, development, manufacturing, and supply of medical countermeasures for crisis situations. Within the field of Emergency Care, the company has built the broadest antidote portfolio in the world, including treatments for nerve agents, cyanide, heavy metal poisoning, and radiation exposure. In addition, its portfolio includes advanced medical countermeasures for the decontamination of the skin in case of exposure to hazardous chemical agents, further strengthening its role in emergency response. With its expertise in CBRN medical countermeasures, SERB supports hospitals, emergency services, health authorities, and governments in addressing major public health risks and responding effectively to chemical, biological, radiological, and nuclear threats.